It promotes the secretion and elimination of bile, the fluid produced by the liver which plays a role in the digestive process
Ultimately, 706 participants met the eligibility criteria and were randomly assigned to one of several treatment arms: once-weekly subcutaneous injections of Cagrilintide at doses of 0.3, 0.6, 1.2, 2.4, or 4.5 mg, once-daily liraglutide 3.0 mg, or a volume-matched placebo
The outcome could determine whether consumers can access compounded versions through a physician rather than relying on products sold outside traditional, authorized medical channels
Its molecular formula is C 78 H 123 N 23 O 23 S 2 , its molecular weight is 1,815.1 g/mol, and its CAS number is 221231-10-3